Drug Pipeline

AZD2287 Clinical Trials

Name: AZD2287 clinical trials — 3 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Top Sponsors

What Changed in the Last 30 Days

First Posted	New Trial Filing	Phase	Status
2026-05-15	NCT07590934 Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic…	Phase 1/2	Not Yet Recruiting

Active Studies by Phase

Phase 1/2

Phase 1

Active Trials

NCT ID	Title	Condition	Status
Phase 1/2
NCT06267729	Study of AZD0754 in Participants With Metastatic Prostate Cancer	Metastatic Prostate Cancer	Recruiting
NCT07590934	Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic…	Metastatic Prostate Cancer	Not Yet Recruiting
Phase 1
NCT06879041	A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant…	Metastatic Castration-Resistant Prostate Cancer	Recruiting

Sponsors Running AZD2287 Trials

AstraZeneca (3)

Disease Areas

Prostate Cancer (3)

Get alerts when AZD2287 trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.